170 related articles for article (PubMed ID: 29459657)
1. Very long-/ and long Chain-3-Hydroxy Acyl CoA Dehydrogenase Deficiency correlates with deregulation of the mitochondrial fusion/fission machinery.
Hagenbuchner J; Scholl-Buergi S; Karall D; Ausserlechner MJ
Sci Rep; 2018 Feb; 8(1):3254. PubMed ID: 29459657
[TBL] [Abstract][Full Text] [Related]
2. Muscle MRI in patients with long-chain fatty acid oxidation disorders.
Diekman EF; van der Pol WL; Nievelstein RA; Houten SM; Wijburg FA; Visser G
J Inherit Metab Dis; 2014 May; 37(3):405-13. PubMed ID: 24305961
[TBL] [Abstract][Full Text] [Related]
3. Very long-chain acyl-coenzyme A dehydrogenase deficiency in Chinese patients: eight case reports, including one case of prenatal diagnosis.
Li X; Ding Y; Ma Y; Liu Y; Wang Q; Song J; Yang Y
Eur J Med Genet; 2015 Mar; 58(3):134-9. PubMed ID: 25652019
[TBL] [Abstract][Full Text] [Related]
4. Tissue-specific strategies of the very-long chain acyl-CoA dehydrogenase-deficient (VLCAD-/-) mouse to compensate a defective fatty acid β-oxidation.
Tucci S; Herebian D; Sturm M; Seibt A; Spiekerkoetter U
PLoS One; 2012; 7(9):e45429. PubMed ID: 23024820
[TBL] [Abstract][Full Text] [Related]
5. Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies.
Fletcher AL; Pennesi ME; Harding CO; Weleber RG; Gillingham MB
Mol Genet Metab; 2012 May; 106(1):18-24. PubMed ID: 22459206
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial energetic impairment in a patient with late-onset glutaric acidemia Type 2.
Xiao C; Astiazaran-Symonds E; Basu S; Kisling M; Scaglia F; Chapman KA; Wang Y; Vockley J; Ferreira CR
Am J Med Genet A; 2020 Oct; 182(10):2426-2431. PubMed ID: 32804429
[TBL] [Abstract][Full Text] [Related]
7. Altered Energetics of Exercise Explain Risk of Rhabdomyolysis in Very Long-Chain Acyl-CoA Dehydrogenase Deficiency.
Diekman EF; Visser G; Schmitz JP; Nievelstein RA; de Sain-van der Velden M; Wardrop M; Van der Pol WL; Houten SM; van Riel NA; Takken T; Jeneson JA
PLoS One; 2016; 11(2):e0147818. PubMed ID: 26881790
[TBL] [Abstract][Full Text] [Related]
8. Rare Korean Cases of Very-long-chain Acyl-CoA Dehydrogenase Deficiency with a Novel Recurrent Mutation.
Ko JM; Seo J; Choi M; Song J; Lee KA; Shin CH
Ann Clin Lab Sci; 2016; 46(1):97-101. PubMed ID: 26927351
[TBL] [Abstract][Full Text] [Related]
9. Effects of fasting, feeding and exercise on plasma acylcarnitines among subjects with CPT2D, VLCADD and LCHADD/TFPD.
Elizondo G; Matern D; Vockley J; Harding CO; Gillingham MB
Mol Genet Metab; 2020; 131(1-2):90-97. PubMed ID: 32928639
[TBL] [Abstract][Full Text] [Related]
10. Subclinical effects of long-chain fatty acid β-oxidation deficiency on the adult heart: A case-control magnetic resonance study.
Knottnerus SJG; Bleeker JC; Ferdinandusse S; Houtkooper RH; Langeveld M; Nederveen AJ; Strijkers GJ; Visser G; Wanders RJA; Wijburg FA; Boekholdt SM; Bakermans AJ
J Inherit Metab Dis; 2020 Sep; 43(5):969-980. PubMed ID: 32463482
[TBL] [Abstract][Full Text] [Related]
11. Neonatal multiorgan failure due to ACAD9 mutation and complex I deficiency with mitochondrial hyperplasia in liver, cardiac myocytes, skeletal muscle, and renal tubules.
Leslie N; Wang X; Peng Y; Valencia CA; Khuchua Z; Hata J; Witte D; Huang T; Bove KE
Hum Pathol; 2016 Mar; 49():27-32. PubMed ID: 26826406
[TBL] [Abstract][Full Text] [Related]
12. The diagnostic challenge in very-long chain acyl-CoA dehydrogenase deficiency (VLCADD).
Hesse J; Braun C; Behringer S; Matysiak U; Spiekerkoetter U; Tucci S
J Inherit Metab Dis; 2018 Nov; 41(6):1169-1178. PubMed ID: 30194637
[TBL] [Abstract][Full Text] [Related]
13. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
[TBL] [Abstract][Full Text] [Related]
14. Recurrent ACADVL molecular findings in individuals with a positive newborn screen for very long chain acyl-coA dehydrogenase (VLCAD) deficiency in the United States.
Miller MJ; Burrage LC; Gibson JB; Strenk ME; Lose EJ; Bick DP; Elsea SH; Sutton VR; Sun Q; Graham BH; Craigen WJ; Zhang VW; Wong LJ
Mol Genet Metab; 2015 Nov; 116(3):139-45. PubMed ID: 26385305
[TBL] [Abstract][Full Text] [Related]
15. Metabolite accumulation in VLCAD deficiency markedly disrupts mitochondrial bioenergetics and Ca
Cecatto C; Amaral AU; da Silva JC; Wajner A; Schimit MOV; da Silva LHR; Wajner SM; Zanatta Â; Castilho RF; Wajner M
FEBS J; 2018 Apr; 285(8):1437-1455. PubMed ID: 29476646
[TBL] [Abstract][Full Text] [Related]
16. Adult-onset very-long-chain acyl-CoA dehydrogenase deficiency (VLCADD).
Fatehi F; Okhovat AA; Nilipour Y; Mroczek M; Straub V; Töpf A; Palibrk A; Peric S; Rakocevic Stojanovic V; Najmabadi H; Nafissi S
Eur J Neurol; 2020 Nov; 27(11):2257-2266. PubMed ID: 32558070
[TBL] [Abstract][Full Text] [Related]
17. One potential hotspot ACADVL mutation in Chinese patients with very-long-chain acyl-coenzyme A dehydrogenase deficiency.
Li X; Ma R; Liu Y; Kang L; He R; Song J; Ren J; Li Y; Huang M; Men J; Yang Y
Clin Chim Acta; 2020 Apr; 503():218-222. PubMed ID: 31794763
[TBL] [Abstract][Full Text] [Related]
18. The safety of Lipistart, a medium-chain triglyceride based formula, in the dietary treatment of long-chain fatty acid disorders: a phase I study.
MacDonald A; Webster R; Whitlock M; Gerrard A; Daly A; Preece MA; Evans S; Ashmore C; Chakrapani A; Vijay S; Santra S
J Pediatr Endocrinol Metab; 2018 Mar; 31(3):297-304. PubMed ID: 29425111
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial bioenergetics deregulation caused by long-chain 3-hydroxy fatty acids accumulating in LCHAD and MTP deficiencies in rat brain: a possible role of mPTP opening as a pathomechanism in these disorders?
Tonin AM; Amaral AU; Busanello EN; Gasparotto J; Gelain DP; Gregersen N; Wajner M
Biochim Biophys Acta; 2014 Sep; 1842(9):1658-67. PubMed ID: 24946182
[TBL] [Abstract][Full Text] [Related]
20. Mitochondrial morphology, bioenergetics and proteomic responses in fatty acid oxidation disorders.
Raimo S; Zura-Miller G; Fezelinia H; Spruce LA; Zakopoulos I; Mohsen AW; Vockley J; Ischiropoulos H
Redox Biol; 2021 May; 41():101923. PubMed ID: 33725513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
